← Leaderboards
Lynn B Dustin
Rockefeller University
$5,526,685
Attributed
$5,526,685
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $847.5K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,526,685 · 3
By mechanism
R01$5,498,389 · 2
M01$28,296 · 1
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- Jeffrey Victor Ravetch$66,226,718
- Marina Caskey$39,777,285
- Brett D. Lindenbach$10,442,003
- Charles M. Rice$80,497,748
- Edgar D Charles$802,000
Others in their field
Top investigators on “Hepatitis C Virus”
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Sharon A Nachman · Johns Hopkins University$91,575,784
- Peter B. Gilbert · Fred Hutchinson Cancer Center$77,122,577
- Robert Turner Schooley · University Of Colorado Denver$45,719,253
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$44,694,148
- Charles M. Rice · Rockefeller University$42,549,577
Research focus
Hepatitis C VirusVirus DiseasesBinding (Molecular Function)Hepatitis CVirusInfectionCellsBaseMediatingMalignant Neoplasm Of LiverViralAnti-Hepatitis CInfectious HepatitidesAntiviral AgentsViral RnaLearningIn VivoLiverProductionChronic Hepatitis CGenesIn VitroLiver CirrhosisSignal Transduction
Grant awards (18)
Immune complexes: Origins and effects in HCV infection$270,000
R01 · FY2015 · AI · contact PI
Novel antiviral activities of tumor necrosis factor-alpha$270,000
R01 · FY2015 · AI · contact PI
Immune complexes: Origins and effects in HCV infection$270,000
R01 · FY2014 · AI · contact PI
Novel antiviral activities of tumor necrosis factor-alpha$270,000
R01 · FY2014 · AI · contact PI
Novel antiviral activities of tumor necrosis factor-alpha$253,800
R01 · FY2013 · AI · contact PI
Immune complexes: Origins and effects in HCV infection$253,800
R01 · FY2013 · AI · contact PI
Novel antiviral activities of tumor necrosis factor-alpha$423,750
R01 · FY2012 · AI · contact PI
Immune complexes: Origins and effects in HCV infection$423,750
R01 · FY2012 · AI · contact PI
Novel antiviral activities of tumor necrosis factor-alpha$423,750
R01 · FY2011 · AI · contact PI
Immune complexes: origins and effects in HCV infection$422,500
R01 · FY2010 · AI · contact PI
Immune complexes: origins and effects in HCV infection$422,500
R01 · FY2009 · AI · contact PI
Immune complexes: origins and effects in HCV infection$400,606
R01 · FY2007 · AI · contact PI
Immune complexes: origins and effects in HCV infection$412,571
R01 · FY2006 · AI · contact PI
Immune complexes: origins and effects in HCV infection$421,979
R01 · FY2005 · AI
HEPATITIS C VIRUS AND THE HUMORAL IMMUNE SYSTEM$18,183
M01 · FY2005 · RR
Immune complexes: origins and effects in HCV infection$421,250
R01 · FY2004 · AI
Hepatitis C virus and the humoral immune system$10,113
M01 · FY2004 · RR
Immune complexes: origins and effects in HCV infection$138,133
R01 · FY2003 · AI